Hepatitis C has a cure. Yet the bloodborne virus causes hundreds of thousands of preventable deaths around the world every year, and structural barriers in the health care system prevent the most at-risk population—people who inject drugs—from accessing testing and treatment. A March study published in The Lancet Regional Health — Americas highlights one particular strategy that could dramatically improve hep C treatment access for people who u…